
Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases. The company's Rezafungin is a novel molecule in the echinocandin class of antifungals. It is developing rezafu... Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases. The company's Rezafungin is a novel molecule in the echinocandin class of antifungals. It is developing rezafungin for the first-line treatment and prevention of serious, invasive fungal infections which are associated with high mortality rates. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.335 | 0.654808444097 | 51.16 | 55.75 | 47.69 | 848503 | 52.35441617 | CS |
4 | 28.895 | 127.853982301 | 22.6 | 56.8288 | 20.16 | 1652224 | 47.83986872 | CS |
12 | 29.375 | 132.798372514 | 22.12 | 56.8288 | 18.505 | 615774 | 43.42039611 | CS |
26 | 31.075 | 152.179236043 | 20.42 | 56.8288 | 15.22 | 364551 | 38.98468573 | CS |
52 | 39.125 | 316.289409863 | 12.37 | 56.8288 | 10.14 | 203028 | 36.69077417 | CS |
156 | 37.365 | 264.437367304 | 14.13 | 56.8288 | 9.202 | 707300 | 24.79142922 | CS |
260 | -23.705 | -31.522606383 | 75.2 | 87 | 8 | 620844 | 29.01690123 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.